Researchers at the University of California San Diego have developed a large-scale screening approach that identifies ...
In a recent study published in Cell, a research team led by Li Wei and Zhou Qi from the Institute of Zoology of the Chinese Academy of Sciences has developed an innovative gene-writing technology ...
RNA interference (RNAi) therapeutics have garnered significant attention in clinical research due to their potential for treating various diseases, including genetic disorders, viral infections and ...
RNA interference (RNAi) is a fundamental cellular mechanism that regulates gene expression by inducing sequence-specific mRNA degradation. Researchers could utilize the RNAi as a powerful tool to ...
The expanded licensing lets AviadoBio pursue partnerships for broader applications, including cardiovascular, nephrology, ...
AviadoBio Ltd. ("AviadoBio"), a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, and King's College London ...
The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular ...
Researchers at the University of Kentucky Sanders-Brown Center on Aging are working to develop a pre-symptomatic disease diagnostic tool for Alzheimer's disease. "While the need for better treatments ...
Genes are not passed on exclusively from parents to their offspring. Some are mobile and can also jump to other species, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results